Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Client Area Book a 7-day Readout
Attomarker logo — Award-winning company empowering patients through gold-stand...

Attomarker

Award-winning company empowering patients through gold-standard rapid diagnostics

Founded 2009 United Kingdom Exeter, United Kingdom 16 employees Convertible Note Biotechnology, Health Care +3

General Information

Company Name Attomarker
Founded Year 2009
Location United Kingdom Exeter, United Kingdom
Employees 16
Industries Biotechnology, Health Care, Health and Wellness +2
Funding Stage Convertible Note
Social

BounceWatch is an independent company data service, not affiliated with Attomarker. To contact Attomarker, visit attomarker.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Attomarker compare?

A PDF of Attomarker and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Attomarker soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Attomarker

Attomarker is an award-winning company with the slogan of "Empowering patients through gold-standard rapid diagnostics." The company's mission is to revolutionize the diagnostics field by providing rapid, accurate, and quantified point-of-care testing solutions. Currently, they have a significant pipeline of tests focused on global health challenges like Long Covid, COVID-19, Liver Health, Diabetes, Obesity, and Antimicrobial Resistance (AMR). The company's Long Covid research test is already available in the UK, Switzerland, and Cyprus, with plans for further expansion in the USA, India, Singapore, and the Cayman Islands. Attomarker, founded in 2009, has developed a technology for measuring multiple biomarkers in blood and saliva to provide a comprehensive health profile in 7-10 minutes. The innovative gold-based nanophotonic technology used by Attomarker has garnered attention and has received several prestigious awards for innovation. Moreover, the company has been granted research funds by the UK Government. Attomarker's groundbreaking work aims to empower healthcare professionals and patients, ultimately leading to improved patient outcomes and lives saved. For more information about their technology, one can visit their website, www.attomarker.com, or contact them directly via email at [email protected].

No funding data available for Attomarker yet.

FAQ About Attomarker

Award-winning company empowering patients through gold-standard rapid diagnostics
Attomarker was founded in 2009.
Attomarker is headquartered in Exeter, United Kingdom.
Attomarker operates in Biotechnology, Health Care, Health and Wellness, Life Sciences and Medical Devices.
Attomarker has approximately 16 employees.

We're actively collecting intelligence on Attomarker.

Source: BounceWatch company record for Attomarker, https://bouncewatch.com/company/attomarker, updated 8 January 2025. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout